COVID Pandemic has Severely Disrupted Sleep, Increasing Stress, Medication Use by Iswarya on December 17, 2020 at 11:54 AM
Journal of Sleep Research.
The global pandemic s impact on daily routines extends to the bed, according to Profiles of sleep changes during the COVID-19 pandemic: Demographic, behavioural and psychological factors . The study was led by Principal Investigator Rébecca Robillard, an Assistant Professor and co-director of the Sleep Laboratory of the School of Psychology at the University of Ottawa, and Head Scientist in the Sleep Research Unit at The Royal Institute of Mental Health Research and published in the Journal of Sleep Research.
Dr. Robillard and her team, which was comprised of nearly two dozen scientists from across North America, conducted an online survey of 5,525 Canadian during the early phase of the COVID-19 pandemic. She walked us through some of the study s most important findings.
E-Mail
IMAGE: Principal Investigator Rébecca Robillard, an Assistant Professor and co-director of the Sleep Laboratory of the School of Psychology at the University of Ottawa, and Head Scientist in the Sleep Research. view more
Credit: University of Ottawa
OTTAWA, ON The COVID-19 pandemic is seriously affecting the sleep habits of half of those surveyed in a new study from The Royal and the University of Ottawa, leading to further stress and anxiety plus further dependence on sleep medication.
The global pandemic s impact on daily routines extends to the bed, according to Profiles of sleep changes during the COVID?19 pandemic: Demographic, behavioural and psychological factors . The study was led by Principal Investigator Rébecca Robillard, an Assistant Professor and co-director of the Sleep Laboratory of the School of Psychology at the University of Ottawa, and Head Scientist in the Sleep Research Unit at The Royal Institute of Mental Health Research and publish
Microdose Psychedelic Insights is pleased to present our first custom event series, leveraging the platform strengths of our Psychedelic Operating System.
Mydecine Speakers Series: Psychedelic Innovations is a virtual event that will explore how current research is igniting mainstream medical interest to unlock the potential of psychedelic therapies. We invite you to join us as we explore the incredible findings around current psychedelic research and potential paths to mainstream acceptance. Grab your
free tickets today and join us Dec. 15th from 12:00 – 1:30 pm EST.
Expert Panelists, Fantastic Perspectives
Panelists will be asked to reflect on the past, present, and future potential of the psychedelic space in relation to the mental health crisis. Mydecine Innovation Group‘s very own Robert Roscow (Chief Scientific Officer & Co-Founder), Dr. Rakesh (Chief Medical Officer), and Dr. Robin Carhart-Harris (Scientific Advisory Board Member) will all be speaking.